NCT00426621

Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis

A 12-Week, Randomized, Double-Blind, Multi-Center, Vehicle-Controlled, Parallel Group Study to Assess the Efficacy and Safety of the Diclofenac Sodium Gel 1% for the Relief of Signs and Symptoms in Patients With Osteoarthritis of the Knee.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 420 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 35 Years
• Healthy volunteers: Not accepted

Summary

This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of knee osteoarthritis.

Conditions

• Osteoarthritis of the Knee

Interventions

Type	Name	Description
DRUG	Diclofenac Sodium Gel	4 grams per knee, 4 times per day, for 12 weeks
DRUG	Placebo	4 grams per knee, 4 times per day, for 12 weeks

Timeline

• Start date: 2006-11-01
• Completion: 2007-06-01
• First posted: 2007-01-25
• Last updated: 2007-12-18

Locations

64 sites across 1 country: United States